Tempus AI (NASDAQ:TEM) Upgraded at TD Cowen

Key Points

• TD Cowen upgraded Tempus AI from "hold" to "buy" with a $65 price target, implying a 51.37% upside from the prior close.
• Analyst consensus is a Moderate Buy (nine Buys, three Holds, two Sells) with a consensus target of $71.36 and individual price targets ranging roughly from $60 to $95.
• The stock opened at $42.94 (1-year range $38.79–$104.32) with a $7.68B market cap and high volatility (beta 4.90); insiders have sold about 563,841 shares (~$32.3M) in the past 90 days while still owning 26.27% of the company.

Tempus AI (NASDAQ:TEM - Get Free Report) was upgraded by equities research analysts at TD Cowen from a "hold" rating to a "buy" rating in a research report issued to clients and investors on Monday,Finviz reports. The brokerage presently has a $65.00 target price on the stock. TD Cowen's price target indicates a potential upside of 51.37% from the stock's previous close.

Several other research analysts also recently weighed in on the company. Morgan Stanley dropped their price target on Tempus AI from $85.00 to $70.00 and set an "overweight" rating for the company in a research note on Tuesday, March 3rd. JPMorgan Chase & Co. dropped their price target on Tempus AI from $80.00 to $60.00 and set a "neutral" rating for the company in a research note on Wednesday, February 25th. Weiss Ratings restated a "sell (d-)" rating on shares of Tempus AI in a research note on Thursday, January 22nd. HC Wainwright upped their price objective on Tempus AI from $89.00 to $95.00 and gave the stock a "buy" rating in a report on Monday, March 9th. Finally, Canaccord Genuity Group decreased their price objective on Tempus AI from $95.00 to $80.00 and set a "buy" rating on the stock in a report on Monday, December 22nd. Nine investment analysts have rated the stock with a Buy rating, three have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, Tempus AI has an average rating of "Moderate Buy" and a consensus target price of $71.36.

Tempus AI Stock Performance

TEM stock opened at $42.94 on Monday. Tempus AI has a 1-year low of $38.79 and a 1-year high of $104.32. The company has a debt-to-equity ratio of 2.52, a current ratio of 3.13 and a quick ratio of 3.00. The company has a market capitalization of $7.68 billion, a price-to-earnings ratio of -30.45 and a beta of 4.90. The business has a 50 day simple moving average of $51.10 and a two-hundred day simple moving average of $66.77.

Insider Buying and Selling at Tempus AI

In other news, CEO Ryan Fukushima sold 9,592 shares of the company's stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $59.05, for a total transaction of $566,407.60. Following the sale, the chief executive officer directly owned 694,354 shares of the company's stock, valued at $41,001,603.70. This represents a 1.36% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Ryan M. Bartolucci sold 2,902 shares of the company's stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $59.05, for a total value of $171,363.10. Following the sale, the chief accounting officer directly owned 41,159 shares in the company, valued at $2,430,438.95. This trade represents a 6.59% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 563,841 shares of company stock worth $32,258,311. Company insiders own 26.27% of the company's stock.

Institutional Trading of Tempus AI

Several hedge funds and other institutional investors have recently bought and sold shares of TEM. Cranbrook Wealth Management LLC purchased a new stake in Tempus AI during the 3rd quarter valued at $25,000. JPL Wealth Management LLC purchased a new stake in Tempus AI during the 3rd quarter valued at $26,000. Los Angeles Capital Management LLC purchased a new stake in Tempus AI during the 4th quarter valued at $27,000. GAMMA Investing LLC purchased a new stake in Tempus AI during the 3rd quarter valued at $28,000. Finally, Harvest Fund Management Co. Ltd purchased a new stake in Tempus AI during the 3rd quarter valued at $38,000. Hedge funds and other institutional investors own 24.22% of the company's stock.

About Tempus AI

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company's core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.